A comprehensive toolkit for analyzing cell-free DNA genomic sequencing data in liquid biopsy

Liquid biopsy via plasma cell-free DNA (cfDNA) is transforming precision medicine by enabling non-invasive insights into the genomic and epigenomic landscapes of disease, especially cancer. However, the increasing diversity of cfDNA-derived features and machine learning applications has outpaced the availability of unified, versatile computational tools. To bridge this gap, we present cfDNAanalyzer-a user-friendly toolkit for streamlined cfDNA analysis, integrating feature extraction, selection, and machine learning model construction. Designed mainly for researchers and clinicians with limited bioinformatics expertise, it supports multimodal integration, interpretable output, and automated preprocessing. Benchmarking against existing toolkits demonstrated that cfDNAanalyzer provides broader feature coverage, efficient runtime, and comparable or improved predictive accuracy across shared feature types. We demonstrate its utility using real-world cfDNA datasets, uncovering its capability to discover biologically meaningful signals and improve diagnostic performance through feature integration. By standardizing and accelerating cfDNA analysis, cfDNAanalyzer enables reproducible biomarker discovery and advances translational liquid biopsy research.

Authors

Institutions

Publication Details

Journal
iScience
Published
2026-04-21
DOI
https://doi.org/10.1016/j.isci.2026.115829
Primary Topic
Cancer Genomics and Diagnostics
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

A comprehensive toolkit for analyzing cell-free DNA genomic sequencing data in liquid biopsy

Yumei Li, Junpeng Zhou, Jinqi Yuan, Xiaoqian Huang et al.
iScience
Cancer Genomics and Diagnostics
article

A comprehensive toolkit for analyzing cell-free DNA genomic sequencing data in liquid biopsy

Yumei Li, Junpeng Zhou, Jinqi Yuan, Xiaoqian Huang, Keyao Zhu
article en

Abstract

Liquid biopsy via plasma cell-free DNA (cfDNA) is transforming precision medicine by enabling non-invasive insights into the genomic and epigenomic landscapes of disease, especially cancer. However, the increasing diversity of cfDNA-derived features and machine learning applications has outpaced the availability of unified, versatile computational tools. To bridge this gap, we present cfDNAanalyzer-a user-friendly toolkit for streamlined cfDNA analysis, integrating feature extraction, selection, and machine learning model construction. Designed mainly for researchers and clinicians with limited bioinformatics expertise, it supports multimodal integration, interpretable output, and automated preprocessing. Benchmarking against existing toolkits demonstrated that cfDNAanalyzer provides broader feature coverage, efficient runtime, and comparable or improved predictive accuracy across shared feature types. We demonstrate its utility using real-world cfDNA datasets, uncovering its capability to discover biologically meaningful signals and improve diagnostic performance through feature integration. By standardizing and accelerating cfDNA analysis, cfDNAanalyzer enables reproducible biomarker discovery and advances translational liquid biopsy research.

iScienceVol. 29(5)
Peking University (CN), Soochow University (CN), Center for Life Sciences (CN)
National Natural Science Foundation of China, Natural Science Foundation of Jiangsu Province
Zero hunger
Openalex Percentile: Top 19%
Cancer Genomics and Diagnostics
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.